Lisata Therapeutics, Inc. (LSTA)
NASDAQ·Healthcare·Biotechnology
$3.19
+2.24%
Mkt Cap $44.46M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $100.00K | $100.00K | +0.00% | -$0.51 | -$0.33 | +35.29% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.54 | -$0.49 | +9.26% | — | — |
| Q3 2025 Aug 7, 2025 | — | $70.00K | — | -$0.65 | -$0.54 | +16.92% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.53 | -$0.55 | -3.77% | — | — |
| Q1 2025 Feb 27, 2025 | — | $1.00M | — | -$0.76 | -$0.55 | +27.63% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.75 | -$0.59 | +21.33% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.75 | -$0.61 | +18.67% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.73 | -$0.65 | +10.96% | — | — |
| Q1 2024 Feb 29, 2024 | — | — | — | -$0.86 | -$0.66 | +23.26% | — | — |
| Q4 2023 Nov 2, 2023 | — | — | — | -$0.93 | -$0.65 | +30.11% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.70 | -$0.50 | +28.57% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.81 | -$0.77 | +4.94% | — | — |
| Q1 2023 Mar 30, 2023 | — | $121.37M | — | -$0.96 | -$0.76 | +20.83% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.90 | -$1.47 | -63.33% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$1.45 | -$1.65 | -13.79% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$1.45 | -$1.05 | +27.59% | — | — |
| Q1 2022 Mar 22, 2022 | — | — | — | -$2.17 | -$1.65 | +23.96% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$2.25 | -$1.80 | +20.00% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$2.17 | -$1.50 | +30.88% | — | — |
| Q2 2021 May 6, 2021 | $660.00K | — | — | -$1.27 | -$2.85 | -124.41% | — | — |